诺华制药

$诺华制药(NVS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-26-010334  Act: 33  Size: 203 KB 网页链接

$诺华制药(NVS)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001114448-26-000004  Act: 34  Size: 39 MB 网页链接

$诺华制药(NVS)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001114448-26-000006  Act: 34  Size: 51 KB 网页链接

$诺华制药(NVS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001114448-26-000007  Act: 34  Size: 1 MB 网页链接

$诺华制药(NVS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001114448-26-000008  Act: 34  Size: 11 MB 网页链接

$诺华制药(NVS)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-26-004590  Act: 33  Size: 482 KB 网页链接

$诺华制药(NVS)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-26-004592  Act: 33  Size: 1 MB 网页链接

$诺华制药(NVS)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-26-004591  Act: 33  Size: 883 KB 网页链接

$诺华制药(NVS)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-26-004593  Act: 33  Size: 515 KB 网页链接

$诺华制药(NVS)$ DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Accession Number: 0001104659-26-003727  Size: 24 KB 网页链接

$诺华制药(NVS)$ DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Accession Number: 0001104659-26-002891  Size: 33 KB 网页链接

$诺华制药(NVS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-007547  Act: 34  Size: 32 KB 网页链接

$诺华制药(NVS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-007445  Act: 34  Size: 72 KB 网页链接

$诺华制药(NVS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-107058  Act: 34  Size: 971 KB 网页链接

$诺华制药(NVS)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-106338  Act: 33  Size: 1 MB 网页链接

$诺华制药(NVS)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-25-105776  Act: 34  Size: 121 KB 网页链接

$诺华制药(NVS)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-105278  Act: 33  Size: 811 KB 网页链接

$诺华制药(NVS)$ DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Accession Number: 0001104659-25-103267  Size: 27 KB 网页链接

$诺华制药(NVS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-103023  Act: 34  Size: 4 KB 网页链接

$诺华制药(NVS)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-25-102943  Size: 101 KB 网页链接